News

Time flies when you are having fun; it is already a bit more than 1 year that Marc Penders joined RiboPro. As Head of Production, he has coordinated the synthesis […]

Do you like to work with messenger RNA, but not sure how to start? Are you wondering about what experimental parameters to keep an eye on? Then we have a […]

Now mRNA has proven its worth as a vaccination agent, more and more researchers are becoming aware of the benefits of mRNA for vaccination, therapy and research purposes. However, a […]

Silvy is a seasoned executive, with extremely valuable experience in scaling a science-driven start-up, and an experienced scientist as well. From the 1st of May on, she will employ those […]

Recently our founder and CEO, Sander van Asbeck, was interviewed by Jan Taco te Gussinklo for ReportersOnline. In this article, they discussed the role of mRNA in the near and […]

On the second of April 2021, RiboPro is officially 1 year old and that is cause for celebration. Especially, since we started during a difficult time, in which lab-access, funding […]

Monday 22 March 2021, Oss, the Netherlands – RiboPro announced it has successfully closed a funding round of €1.2 million, led by Stichting Vlasroot, with a consortium of BOM, Rockstart […]

Today, the 18th of March, we launch our new website. With this website, we will build a center of knowledge on mRNA, readily available to our customers. In addition, we […]

RNAses are a major concern for everyone working with messenger RNA, since minor contamination with RNAse can quickly compromise the mRNA in your sample or application. When ordering mRNA from […]